SEO URLwww.firestrike.ai/deals/revolution-medicines-merck-acquisition-2026-4
acquisitionAnnounced · Jan 9, 2026biotechnologySource · CredibleArticle · Factual
Merck acquires Revolution Medicines
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Revolution Medicines
NASDAQ:RVMD
Acquirer
Merck
Full Acquisition
Status
Pending
Merck agreed to acquire Revolution Medicines. Reported deal value: Undisclosed. Status: Pending. Sector: biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-09. Figures and status may change as filings and press coverage update.
Key facts : Merck in talks to acquire Revolution Medicines
Deal timeline
Announced
Jan 9, 2026 · tradingview.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotechnology. Figures and status may change as sources update.
Sources: tradingview.com · Primary article · FireStrike proprietary index